Antivenin (Latrodectus mactans)
Antivenin (Latrodectus mactans) is an FDA-licensed reference biologic from Merck Sharp & Dohme LLC. Reference exclusivity, biosimilar lineage, and published patents from official FDA Purple Book records.
0
Biosimilars
0
Interchangeables
0
Listed patents
1936
Reference approved
Reference product
Not listed Antivenin (Latrodectus mactans)
Merck Sharp & Dohme LLC
- Approved
- Feb 13, 1936
- Marketing
- Rx
- Center
- CBER
- Patents
- None listed
Exclusivity & patent cliffs
Approval, exclusivity, and published-patent expiration dates for Antivenin (Latrodectus mactans), in chronological order.
Reference approval
Approval date of the reference Antivenin (Latrodectus mactans) product.
91 yr 7 mo ago
Frequently asked questions
Are there biosimilars approved for Antivenin (Latrodectus mactans)?
No 351(k) biosimilars or interchangeable biosimilars referencing Antivenin (Latrodectus mactans) are listed in the FDA Purple Book yet.
Explore the full FDA Purple Book
Search every FDA-licensed biologic, biosimilar, and interchangeable with exclusivity timelines and patent records.